Evidence map›Paper›PMID 35489000›Full record

ArticleEndocrine2022

Prospective study on the clinical relevance of

Inés Califano, Fabián Pitoia, Roxana Chirico, Alejandra De Salazar, María José Bastianello

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Endocrine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Inés CalifanoDepartment of Endocrinology, Instituto de Oncología AH Roffo, Ciudad Autónoma de Buenos Aires, Argentina. ines.m.califano@gmail.com.ORCID 0000-0002-7450-5832
Fabián PitoiaDivision of Endocrinology, Hospital de Clínicas, University of Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-2742-7085
Roxana ChiricoMolecular Imaging and Metabolic Therapy Section. Imaging Department, University Hospital CEMIC, Galván 4102. CP 1414, Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-3278-0764
Alejandra De SalazarMolecular Imaging and Metabolic Therapy Section. Imaging Department, University Hospital CEMIC, Galván 4102. CP 1414, Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-3398-8460
María José BastianelloMolecular Imaging and Metabolic Therapy Section. Imaging Department, University Hospital CEMIC, Galván 4102. CP 1414, Ciudad Autónoma de Buenos Aires, Argentina.ORCID 0000-0002-3254-1800
Centro de Educación Médica e Investigaciones Clínicas Norberto Quirno · ARInstituto de Neurología de Buenos Aires · ARUniversidad de Buenos Aires · AR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose

methodsThirty-six patients with MTC and Ctn levels ≥150 pg/ml were prospectively included. Neck ultrasound, chest contrast-enhanced CT, liver magnetic resonance imaging/abdominal three-phase contrast-enhanced CT and bone scintigraphy were carried out up to 6 months before the

resultsSeventy eight percent of patients were female and 27% had hereditary MTC. Median Ctn level was 1450 pg/ml [150-56620], median CEA level 413 ng/ml [2.9-7436]. Median Ctn DT was 37.5 months [5.7-240]; median CEA DT was 31.8 [4.9-180].

conclusion

Indexed as

Carcinoma, NeuroendocrineThyroid NeoplasmsCalcitoninCarcinoembryonic AntigenDihydroxyphenylalanineFemaleFluorodeoxyglucose F18HumansMalePositron-Emission TomographyPositron Emission Tomography Computed TomographyProspective StudiesCalcitoninCarcinoembryonic AntigenDihydroxyphenylalanineFluorodeoxyglucose F18fluorodopa F 1818F-DOPAMedullary thyroid cancerPET/CTPositron Emission Tomography

Identifiers

PMID35489000
OpenAlexW4225145936

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.